Investors

We are inspired and guided by our core values.
join us

At a glance

Eastra Health Inc. is privately-owned Canadian incorporated headquartered in Toronto, Canada and with operations in California and The United Kingdom. Eastra is currently raising a seed round of equity capital.

Our Guiding Lights

Values – Driven

We are inspired and guided by our core values. Throughout our capital raising activities, we look to partner with investors and funds who share the same or similar values as us, and who conduct themselves in a highly ethical and professional manner. Being a good corporate citizen wherever we operate is part of our DNA.

Alignment of Goals

Eastra Health Inc. is looking to build tangible and significant shareholder value behind the development of medicines that will improve the lives for billions of women. We are mindful that real transformation and value creation could require more time, effort and patience than was expected. Eastra welcomes investors who share our ambitious goals and understand that the biotech drug development journey is sometimes not in a straight line

Good Governance & Risk Management

At the core, Eastra is the custodian of other people’s money. Managing and deploying our investor’s capital and stewarding the firm according to governance best practices are responsibilities we take very seriously.

At the same time, we are part of a broader, global healthcare community that includes patients, physicians, employees, industry associations and business partners. When possible, we will seek to ensure that our strategies and activities are congruent with our stakeholders.

Press Releases

Eastra Health Appoints Veteran Pharmacologist, Neuroscientist Emeline Maillet Ph.D. as Chief Scientific Officer

TORONTO, June 21, 2021 — Eastra Health Inc (EHI or the “Company”) announces Emeline Maillet Ph.D. as Chief Scientific Officer. Dr. Maillet is a leading pharmacologist and neuroscientist with over twenty years of experience in academia and pharmaceuticals identifying and testing novel drug treatments for various conditions. READ MORE >

Femtech Pioneer Eastra Health Launches Psychedelic Biotech to Address Menopause & PMS

TORONTO, June 1, 2021 — Eastra Health Inc (EHI or the “Company”) is the world’s first female-focused biotech company dedicated to developing psychedelic-derived medicines specifically for women. Eastra Health will offer new solutions for under-addressed health conditions – from PMS to menopause – through an innovative approach to drug discovery and a deep & holistic understanding of women’s health, biology, and specific needs. READ MORE >

Downloads

Download the Investment Summary

Forward Looking Statements

This website contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements.” Forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward looking statements. Such risks and uncertainties include, among others, dependence on obtaining and maintaining regulatory approvals, including acquiring and renewing federal, provincial, municipal, local or other licenses and any inability to obtain all necessary governmental approvals licenses and permits to operate and expand the Company’s facilities; engaging in activities which currently are illegal under Canadian federal law and the uncertainty of existing protection from Canadian federal or other prosecution; regulatory or political change such as changes in applicable laws and regulations, including federal and provincial legalization, due to inconsistent public opinion, perception of the psychedelics industry, bureaucratic delays or inefficiencies or any other reasons; any other factors or developments which may hinder market growth; the Company’s limited operating history and lack of historical profits; reliance on management; the Company’s requirements for additional financing, and the effect of capital market conditions and other factors on capital availability, including closing of the financings contemplated herein; competition, including from more established or better financed competitors; and the need to secure and maintain corporate alliances and partnerships, including with customers and suppliers. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although the Company has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. The Company has no obligation to update any forward-looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.